| 000 | 01741 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250511230458.0 | ||
| 264 | 0 | _c19901120 | |
| 008 | 199011s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM199011083231901 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrown, G | |
| 245 | 0 | 0 |
_aRegression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cNov 1990 |
||
| 300 |
_a1289-98 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aApolipoproteins B _xblood |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aColestipol _xadministration & dosage |
| 650 | 0 | 4 | _aCoronary Angiography |
| 650 | 0 | 4 |
_aCoronary Disease _xblood |
| 650 | 0 | 4 | _aDiet |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLovastatin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aNiacin _xadministration & dosage |
| 700 | 1 | _aAlbers, J J | |
| 700 | 1 | _aFisher, L D | |
| 700 | 1 | _aSchaefer, S M | |
| 700 | 1 | _aLin, J T | |
| 700 | 1 | _aKaplan, C | |
| 700 | 1 | _aZhao, X Q | |
| 700 | 1 | _aBisson, B D | |
| 700 | 1 | _aFitzpatrick, V F | |
| 700 | 1 | _aDodge, H T | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 323 _gno. 19 _gp. 1289-98 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM199011083231901 _zAvailable from publisher's website |
| 999 |
_c2221738 _d2221738 |
||